Literature DB >> 6254877

Pathogenicity of wild-type and temperature-sensitive mutants of herpes simplex virus type 2 in guinea pigs.

C A Anderson, M J August, G D Hsiung.   

Abstract

The pathogenicity of herpes simplex virus type 2 strain 186, the wild-type (WT) strain, and four temperature-sensitive (ts) mutants was studied after genital inoculation of female guinea pigs. Infection with the WT virus was generally severe, with extensive skin lesions in 89% and mortality in 37% of inoculated animals. Guinea pigs inoculated with ts mutants manifest remarkably mild disease, with lesions occurring in only 16% of the guinea pits and a mortality rate of 7%. WT virus was recovered from nerve and non-nerve tissues of all acutely infected animals and from the majority of latently infected animals (71%). Virus was isolated from nerve or genital tissues from only 13% of ts mutant-inoculated animals during acute infection and from 7% during latent infection. Three of the seven isolates from mutant-infected animals appeared to be WT virus. Identification of WT and ts mutant isolates was done by biological characterization in selective cell cultures at permissive (33 degrees C) and nonpermissive (38 degrees C) temperatures. One month after initial infection with WT virus, guinea pigs were challenged with the same virus and were completely resistant to overt clinical disease. Animals inoculated with ts mutants A1b and C2b had mild manifestations of disease after challenge with WT virus; however, the capacity of WT virus to establish latent infection was conserved. Although complement-required neutralizing antibodies were detectable after challenge in animals previously inoculated with mutant virus A1b, C2b, or D6b, there was no significant protection against subsequent infection with WT virus. No complement-required neutralizing antibodies were detected in F3b animals after challenge. The present study of WT and ts mutants of herpes simplex virus type 2 in the guinea pig model provides a means for better understanding the mechanisms of pathogenesis and latency after genital infection.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6254877      PMCID: PMC551291          DOI: 10.1128/iai.30.1.159-169.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Herpes simplex virus infection in guinea pigs: an animal model for studying latent and recurrent herpes simplex virus infection.

Authors:  M Scriba
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

2.  Viral gene functions expressed and detected by temperature-sensitive mutants of herpes simplex virus.

Authors:  M Benyesh-Melnick; P A Schaffer; R J Courtney; J Esparza; S Kimura
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

3.  In vivo behaviour of a temperature-sensitive (ts) mutant of herpesvirus hominis type 2.

Authors:  N Zygraich; C Huygelen
Journal:  Arch Gesamte Virusforsch       Date:  1973

4.  Genital herpes in guinea-pigs. An experimental model with Herpesvirus hominis.

Authors:  B Lukás; W Wiesendanger; K H Schmidt-Ruppin
Journal:  Arch Gesamte Virusforsch       Date:  1974

5.  Latent ganglionic infection with herpes simplex virus types 1 and 2: viral reactivation in vivo after neurectomy.

Authors:  M A Walz; R W Price; A L Notkins
Journal:  Science       Date:  1974-06-14       Impact factor: 47.728

6.  Isolation, complementation and preliminary phenotypic characterization of temperature-sensitive mutants of herpes simplex virus type 2.

Authors:  J Esparza; D J Purifoy; P A Schaffer; M Benyesh-Melnick
Journal:  Virology       Date:  1974-02       Impact factor: 3.616

7.  Temperature-sensitive mutants of herpes simplex virus type 1: isolation, complementation and partial characterization.

Authors:  P A Schaffer; G M Aron; N Biswal; M Benyesh-Melnick
Journal:  Virology       Date:  1973-03       Impact factor: 3.616

8.  Recovery of herpes simplex virus from human sacral ganglions.

Authors:  J R Baringer
Journal:  N Engl J Med       Date:  1974-10-17       Impact factor: 91.245

9.  Genital herpesvirus hominis Type 2 infection of monkeys.

Authors:  W T London; L W Catalano; A J Nahmias; D A Fuccillo; J L Sever
Journal:  Obstet Gynecol       Date:  1971-04       Impact factor: 7.661

10.  A search for viruses in smegma, premalignant and early malignant cervical tissues. The isolation of Herpesviruses with distinct antigenic properties.

Authors:  W E Rawls; D Laurel; J L Melnick; J M Glicksman; R H Kaufman
Journal:  Am J Epidemiol       Date:  1968-05       Impact factor: 4.897

View more
  7 in total

1.  Thymidine kinase-deficient herpes simplex virus type 2 genital infection in guinea pigs.

Authors:  L R Stanberry; S Kit; M G Myers
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

2.  Pathogenesis of genital herpes simplex virus infection in mice. III. Comparison of the virulence of wild and mutant strains.

Authors:  K E Schneweis; H Forstbauer; M Olbrich; M Tag
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

3.  Use of guinea pig embryo cell cultures for isolation and propagation of group A coxsackieviruses.

Authors:  M L Landry; H P Madore; C K Fong; G D Hsiung
Journal:  J Clin Microbiol       Date:  1981-03       Impact factor: 5.948

4.  Comparison of guinea pig embryo cells, rabbit kidney cells, and human embryonic lung fibroblast cell strains for isolation of herpes simplex virus.

Authors:  M L Landry; D R Mayo; G D Hsiung
Journal:  J Clin Microbiol       Date:  1982-05       Impact factor: 5.948

5.  Oral acyclovir therapy of genital herpes simplex virus type 2 infections in guinea pigs.

Authors:  M N Ellis; D W Barry
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

6.  Immunization of inbred guinea pigs with varicella-zoster virus grown in a syngeneic transformed embryo cell line.

Authors:  C Grose
Journal:  J Clin Microbiol       Date:  1981-08       Impact factor: 5.948

7.  Interaction of herpesvirus with spleen cell subpopulations comparison of a neurotropic and a lymphotropic virus.

Authors:  T C Chow; G D Hsiung
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.